Biotech Dizal Completes Enrollment for its Phase III Pivotal Study of Sunvozertinib vs. Platinum Doublet in Treatment Naïve NSCLC Patients with EGFR Exon20 Insertional Mutations June 19, 2025
Biotech Oncoinvent Announces Positive Final Data from Phase 1/2a Trial of Radspherin® in Patients with Colorectal Peritoneal Metastases June 18, 2025
Biotech Rewind Therapeutics Strengthens Scientific Advisory Board with Leading International Neurology Experts as it Advances First-in-Class Remyelination Therapy June 18, 2025
Biotech HanchorBio Presents Promising Data on HCB101 Checkpoint Inhibitor Immunotherapy at ASCO June 17, 2025
Biotech Clarivate Identifies Radioligand Therapy Innovators as Companies to Watch in the Future of Precision Oncology June 16, 2025
Biotech HELP Therapeutics and China Resources Sanjiu Announce Strategic Partnership to Co-Develop and Commercialize HiCM-188 for Advanced Heart Failure June 16, 2025
Biotech CureLab Veterinary’s ElenaVet™ Gene Therapy Delivers 90% Success in Pet-Dog Osteoarthritis Study June 14, 2025
Biotech DRI Healthcare Trust Comments on FDA Delay for KalVista Pharmaceuticals’ Sebetralstat PDUFA Goal Date Due to FDA Resourcing Constraints June 14, 2025